Despite some clumsy graphs and none too clear Delphi process which appears to seek to dismiss the utility of prescribing both Memantine and ACHEIs, the updated guidance on prescribing in dementia is very much welcome. The advice hasn’t changed much in ten years. These are drugs of small effect and one must be careful when prescribing antipsychotics as risks are high and benefits often marginal compared to sensitive nursing care. The text refers to European consensus guidance and appears to try to harmonise with it. Sensible advice is given on nutraceuticals and a ray of hope in the promise of disease modifiers.